. Author manuscript; available in PMC: 2020 Jul 1.

Published in final edited form as: Gynecol Oncol. 2019 May 8;154(1):77–82. doi: 10.1016/j.ygyno.2019.04.683

Table 2.

Patient demographics

	N
Median age, years (range)	79 (74 – 88)
Median number of comorbidities (range)	3 (0–8)
Disease status (%)
Newly diagnosed ovarian cancer	38 (90)
Recurrent ovarian cancer / SDS	4 (10)
Stage at initial diagnosis (% new diagnoses)
IIIB	1 (3)
IIIC	26 (68)
IV	11 (29)
Treatment approach (% new diagnoses)
PDS	16 (42)
NACT/IDS	22 (58)
Robotic IDS (% IDS)	3 (14)
Median number of NACT cycles (range)	4 (3–6)
Histology (% new diagnoses)
High grade serous	34 (89)
Carcinosarcoma	1 (3)
Sarcoma	1 (3)
Mesonephric adenocarcinoma	1 (3)
Mixed	1 (3)